INFItech Showcases “Eastern Wisdom, Empowered by Science” at the 8th China International Import Expo(CIIE)
- joey Zhong
- Nov 12
- 2 min read

Shanghai, November 9, 2025 — INFItech Limited, an innovative biopharmaceutical company born from the Hong Kong University of Science and Technology (HKUST), proudly concluded its successful participation at the 8th China International Import Expo (CIIE 2025). Guided by its core philosophy of “Empowering Eastern Wisdom through Science,” INFItech captivated global audiences with a fusion of cutting-edge neuroscience and traditional Chinese herbal innovation, highlighting the harmony between cultural heritage and scientific advancement.

As a featured exhibitor in the Hong Kong Pavilion, INFItech’s flagship brand Cogniherbs drew significant attention from experts, partners, and investors worldwide. The company showcased three of its breakthrough formulations — NerveReform, MotionReform, and VascuReform — each designed to enhance neural vitality, motor coordination, and cerebrovascular function. With the theme “Boost Your Memory, Oxygenate Your Brain,” these products address the growing global demand for natural, safe, and effective brain health solutions tailored for modern lifestyles.


By integrating molecular neuroscience with the wisdom of traditional Chinese medicine, INFItech has built an innovative framework that bridges Eastern pharmacology and modern science. The Cogniherbs series embodies the company’s mission to empower life through science and to illuminate the future through cultural legacy.
At the Expo, INFItech’s Chief Operating Officer stated: “True innovation is deeply rooted in culture. ‘Eastern Wisdom’ represents more than a healing tradition — it is a philosophy of balance and vitality. Our mission is to let this timeless Chinese wisdom be reinterpreted and respected through the lens of modern science.”
Since its founding in 2024, INFItech has established its base in the Hong Kong Science Park and has been a two-time recipient of Hong Kong’s Innovation and Technology Commission’s TSSSU funding. Led by internationally renowned neuroscientists and pharmaceutical experts, the company continues to pioneer research in neurodegenerative diseases and brain health innovation. Moving forward, INFItech remains dedicated to “Empowering Eastern Wisdom through Science” — joining hands with global partners to shape a new era of brain health for humanity.




Comments